{"symbol": "NVLN", "companyName": "Novelion Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.novelion.com", "description": "Novelion Therapeutics Inc is a biopharmaceutical company. It is engaged in developing patient care facility and providing services for people suffering from rare diseases like lipodystrophy, leber congenital amaurosis, and retinitis pigmentosa.", "CEO": "Benjamin Harshbarger", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}